MimiVax Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
Brain cancer awareness, grey ribbon on helping hand

MimiVax Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM

https://www.prweb.com/releases/roswell_park_spinoff_company_advances_toward_new_clinical_trial_for_brain_cancer_immunotherapy_survaxm/prweb16737735.htm MimiVax LLC and Roswell Park to launch large clinical trial at centers in U.S. & abroad following major licensing deal MimiVax LLC secures $10 million upfront in licensing dealLarge…

Continue Reading